The opioid crisis, maternal death, and COVID-19 underscore trust as foundational to public health and call for redefinition of what it means to be a US clinician.
AMA J Ethics. 2021;23(3):E265-270. doi:
10.1001/amajethics.2021.265.
This article considers force use in clinical settings after a triggering event—a behavioral or medical crisis—and considers how it should be implemented.
AMA J Ethics. 2021;23(4):E326-334. doi:
10.1001/amajethics.2021.326.
This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing.
AMA J Ethics. 2021;23(6):E471-479. doi:
10.1001/amajethics.2021.471.
Drs Arya Shah, Carmen Black Parker, and Ambrose H. Wong join us on this episode of Ethics Talk to discuss force, the role of authority, and how clinicians should not just minimize harm but demonstrate compassion.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
COVID-19 underscores historical precedent for fear-driven responses that disregard autonomy among persons with low income who are also persons of color.
AMA J Ethics. 2021;23(11):E840-846. doi:
10.1001/amajethics.2021.840.